All payers | Medicare | Private insurance† | ||||
---|---|---|---|---|---|---|
2005 | 2010 | 2005 | 2010 | 2005 | 2010 | |
n = 393 | n = 455 | n = 393 | n = 455 | n = 393 | n = 455 | |
Mean | Mean | Mean | Mean | Mean | Mean | |
Cost per discharge | 11,097 | 12,712 | 11,110 | 12,570 | 11,099 | 13,173 |
Patient characteristics | ||||||
Age | 66.8 | 66.9 | 77.9 | 77.9 | 53.0 | 53.8 |
Sex | ||||||
Female (%) | 0.55 | 0.54 | 0.58 | 0.57 | 0.53 | 0.52 |
% of Discharges with comorbid conditions | ||||||
Addictive disorders (combined) | 0.15 | 0.21 | 0.11 | 0.15 | 0.14 | 0.20 |
Diabetes (combined) | 0.24 | 0.28 | 0.25 | 0.30 | 0.18 | 0.21 |
General blood disorders (combined) | 0.21 | 0.28 | 0.26 | 0.34 | 0.13 | 0.18 |
General cancers (combined) | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 | 0.04 |
Rheumatoid arthritis/collagen vascular diseases | 0.03 | 0.03 | 0.03 | 0.04 | 0.02 | 0.02 |
Congestive heart failure | 0.10 | 0.10 | 0.15 | 0.15 | 0.03 | 0.03 |
Chronic obstructive pulmonary disease | 0.21 | 0.22 | 0.24 | 0.24 | 0.13 | 0.14 |
Hypertension (combined uncomplicated and complicated) | 0.51 | 0.60 | 0.58 | 0.67 | 0.41 | 0.48 |
Hypothyroidism | 0.10 | 0.14 | 0.13 | 0.17 | 0.07 | 0.09 |
Liver disease | 0.02 | 0.03 | 0.01 | 0.01 | 0.02 | 0.03 |
Fluid and electrolyte disorders | 0.19 | 0.25 | 0.22 | 0.28 | 0.12 | 0.17 |
Other neurological disorders | 0.06 | 0.08 | 0.08 | 0.10 | 0.02 | 0.04 |
Obesity | 0.07 | 0.11 | 0.04 | 0.08 | 0.09 | 0.15 |
Paralysis | 0.02 | 0.03 | 0.02 | 0.03 | 0.01 | 0.01 |
Renal failure | 0.06 | 0.14 | 0.08 | 0.18 | 0.02 | 0.05 |
Solid tumor without metastasis | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 |
Valvular disease | 0.04 | 0.04 | 0.06 | 0.06 | 0.02 | 0.02 |
Weight loss | 0.03 | 0.05 | 0.03 | 0.05 | 0.03 | 0.05 |